Trials under analysis - Oxford University Clinical Research Unit

×

Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection

Study code: VHARP001
Start date: Dec-13 End date: Nov-16
CT registration number: NCT01147107

An Open-label Study to Find the Minimum Inhibitory Concentration(MIC) of KAE609 in Adult Male Patients With Acute, Uncomplicated Malaria Due to Plasmodium Falciparum Monoinfection

Study code: 12MA
Start date: Jan-14 End date: Mar-15
CT registration number: NCT01836458

A Randomised Controlled Trial to Assess the Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam

Study code: 07MA
Start date: Feb-13 End date: Jun-15
CT registration number: NCT01887821

A Randomized, Double Blind, Placebo-Controlled Phase III Trial of Adjunctive Dexamethasone in HIV infected Adults with Cryptococcal Meningitis

Study code: 04CN
Start date: Mar-13 End date: Feb-15
CT registration number: ISRCTN59144167

A randomized, open-label, comparative study of the effectiveness of itraconazole versus amphotericin B in the induction treatment of penicilliosis in HIV-infected adults

Study code: 11CN
Start date: Oct-12 End date: Jun-16
CT registration number: ISRCTN97524945

Randomized, Open-label, Superiority Trial of the Effectiveness of Gatifloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Enteric Fever

Study code: 03NP
Start date: Sep-11 End date: Jan-15
CT registration number: NCT01421693

Double Blind, Placebo Controlled Randomised Trial of Acetazolamide Versus Placebo in the Prevention of Acute Mountain Sickness During Rapid Ascent

Study code: 04NP
Start date: Aug-11 End date: Oct-11
CT registration number: NCT01418157

A multicentre, randomised trial to detect in vivo resistance of Plasmodium falciparum to artesunate in patients with uncomplicated malaria

Study code: 03MA
Start date: May-11 End date: Dec-14
CT registration number: NCT01350856

Intensified Treatment for Tuberculous Meningitis in Adult Patients with Enhanced Rifampicin and Levofloxacin

Study code: 05TB
Start date: Apr-11 End date: Mar-15
CT registration number: ISRCTN61649292

Etiology, Clinical Manifestations and Risk Factors for Community-acquired Pneumonia in Patients Admitted to Hospital

Study code: 03HN
Start date: Feb-11 End date: Feb-14
CT registration number: NCT01336036

Clinical Investigation of In-vivo Susceptibility of P. Falciparum to Artesunate in Phuoc Long Hospital, Binh Phuoc Province, Vietnam

Study code: 02MA
Start date: Aug-10 End date: May-11
CT registration number: NCT01165372

Page 2 of 2«12